Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.42 |
| ▸ | PTPRC | P08575 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19237177 | 1.00 | ALDH1A1 (0.46) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL31713020 | 0.85 | CA1 (0.48) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL29124878 | 0.82 | ALDH1A1 (0.46) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL22182094 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL5055109 | 0.80 | MAPT (0.57) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL29679284 | 0.80 | PTPRC (0.57) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL20123135 | 0.80 | ALDH1A1 (0.39) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL29403074 | 0.80 | MAPT (0.57) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL2079031 | 0.80 | PTPRC (0.57) | ALDH1A1MAPK1MAPTL3MBTL1POLB | |
| SCHEMBL27712873 | 0.80 | PTPRC (0.59) | ALDH1A1MAPK1MAPTL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0257260-A1 | Process for the hydrogenation treatment of mineral oils contaminated by chlorobiphenyls | VEBA OEL Technologie und Automatisierung GmbH (DE) | 1988-03-02 | — | — | EP | claimed |
| US-20240373742-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-11-07 | — | — | US | disclosed |
| CN-118834226-A | Organic electroluminescent material and device | 环球展览公司 | 2024-10-25 | — | — | CN | disclosed |
| US-20020022151-A1 | Organic electroluminescent device | NEC CORPORATION (JP) | 2002-02-21 | — | — | US | disclosed |
| EP-0721933-B1 | 1,4-Disubstituted 2,6-difluorobenzene compounds and liquid crystal media | MERCK PATENT GMBH (DE) | 1999-07-07 | — | — | EP | disclosed |
| EP-0462237-B1 | 1,2-DISUBSTITUTED 2,6-DIFLUOROBENZENE COMPOUNDS AND LIQUID CRYSTAL MEDIA | MERCK PATENT GMBH (DE) | 1997-03-12 | — | — | EP | disclosed |
| EP-0721933-A1 | 1,4-Disubstituted 2,6-difluorobenzene compounds and liquid crystal media | MERCK PATENT GmbH (DE) | 1996-07-17 | — | — | EP | disclosed |
| EP-0462237-A1 | 1,2-DISUBSTITUTED 2,6-DIFLUOROBENZENE COMPOUNDS AND LIQUID CRYSTAL MEDIA. | MERCK PATENT GMBH (DE) | 1991-12-27 | — | — | EP | disclosed |
| EP-0113252-B1 | PROCESS FOR PRODUCING BLOCK COPOLYAMIDE | TORAY INDUSTRIES, INC. (JP) | 1991-08-07 | — | — | EP | disclosed |
| WO-1991008184-A2 | 1,2-DISUBSTITUTED 2,6-DIFLUOROBENZENE COMPOUNDS AND LIQUID CRYSTAL MEDIA | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1991-06-13 | — | — | WO | disclosed |
| WO-1989003812-A1 | CROSS COUPLING OF TITANIUM ORGANYLS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1989-05-05 | — | — | WO | disclosed |
| EP-0282542-A1 | PROCESS FOR THE PRODUCTION OF ALKYLENE OR CYCLICALLY LINKED COMPOUNDS. | MERCK PATENT GMBH (DE) | 1988-09-21 | — | — | EP | disclosed |
| WO-1988002357-A2 | PROCESS FOR THE PRODUCTION OF ALKYLENE OR CYCLICALLY LINKED COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-04-07 | — | — | WO | disclosed |
| EP-0257260-A1 | Process for the hydrogenation treatment of mineral oils contaminated by chlorobiphenyls | VEBA OEL Technologie und Automatisierung GmbH (DE) | 1988-03-02 | — | — | EP | disclosed |
| EP-0257260-A1 | Process for the hydrogenation treatment of mineral oils contaminated by chlorobiphenyls | VEBA OEL Technologie und Automatisierung GmbH (DE) | 1988-03-02 | — | — | EP | disclosed |
| US-4507465-A | IMPACT STRENGTH | TORAY INDUSTRIES, INC. (JP) | 1985-03-26 | — | — | US | disclosed |
| EP-0113252-A2 | Process for producing block copolyamide | TORAY INDUSTRIES, INC. (JP) | 1984-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240373742-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, ODC1 | ALDH1A1 526/4885MAPK1 4452/4885MAPT 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.